About
Fountain Healthcare Partners is a life science focused venture capital fund with over EUR 300 million under management. Within the life science sector, specific areas of interest to Fountain Healthcare Partners include biotechnology, medical devices, specialty pharma and diagnostics. To date, Fountain has invested in the gene therapy space in both ophthalmology and cardiology. Fountain invests in entrepreneurs and companies with disruptive technologies or products that have a clear pharmacoeconomic benefit and a defined pathway to commercialisation, value enhancement and exit. Fountain’s main office is in Dublin, Ireland, with a second office in New York. The firm deploys the majority of its capital in Europe, with the balance in the United States.
Ena Prosser
PartnerVenture Capital Investment 353868164618
ena.prosser@fh-partners.com
Website
View WebsiteAddress
Two Docklands Central Guild Street
Dublin
D01K2T8
Ireland
ena.prosser@fh-partners.com
Areas of Expertise
- Cell therapy (Allogeneic)
- Cell Therapy (Autologous)
- Chemical synthesis
- Clinical
- Delivery
- Discovery
- Gene Therapy (non-viral)
- Gene therapy (viral)
- RNA
